Microbio is an Australian biotech startup that plans to change the course of pathogen detection. Our novel diagnostic method combines the latest advances in bioinformatics, genomics and molecular microbiology to deliver rapid pathogen detection using qPCR. Developed in collaboration with Australian clinicians, Microbio’s flagship product InfectID-BSI has been designed with clinical decision-making in mind, to… Continue reading Introducing Microbio
Tag: test
Microbio appoints Colin Keating as CEO
Brisbane, 24 October 2023 – Microbio Ltd, an Australian molecular pathogen diagnostics company, is pleased to announce the appointment of Colin Keating as CEO, effective from 1 November 2023. Mr Keating joined Microbio as interim COO in May and assumed the role of interim CEO in early June. Mr Keating’s experience delivering transformation programs at… Continue reading Microbio appoints Colin Keating as CEO
Microbio featured on Smart Company
Microbio has been featured by Smart Company in an article highlighting the commercialisation of InfectID-BSI and how it has benefitted from our participation in the Brisbane Economic Development Agency’s MedTech Accelerator program. Microbio develops pathogen test to identify and treat sepsis (smartcompany.com.au)
Microbio appoints Jeff Bryant to drive global commercial strategy
Microbio Ltd, an Australian pathogen detection diagnostics company, is pleased to announce the appointment of Jeff Bryant as its Commercial Director. Mr Bryant will lead the company’s commercial team as it executes its global commercialisation strategy. With his extensive experience in market entry strategy, sales growth, and sales channel development, Mr Bryant brings valuable expertise… Continue reading Microbio appoints Jeff Bryant to drive global commercial strategy
Microbio closes latest investment round after surpassing $3.5m target
Queensland biotechnology scale-up Microbio has closed its latest investment round after surpassing its $3.5 million target. This investment will facilitate Microbio expanding regulatory approval into international markets, having already received clearance for distribution and use in Europe and the UK, with approval in India and South America expected by the end of 2022, and TGA… Continue reading Microbio closes latest investment round after surpassing $3.5m target